New drug combo shows promise against tough esophageal cancer
NCT ID NCT00213486
First seen Apr 25, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study tested a weekly combination of two chemotherapy drugs (cisplatin and irinotecan) along with radiation in 43 people with advanced esophageal cancer that had not spread. The main goal was to see if the cancer completely disappeared after treatment. Researchers also tracked side effects and how long people lived. This approach aims to control the disease rather than cure it, as ongoing management is typically needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Rouen
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.